China’s exports seen rising in April but at slower pace, outlook challenging

By Joe Cash BEIJING (Reuters) -China’s exports were expected to have risen again in April, albeit at a less robust pace than a month earlier, a Reuters poll showed, supported by unfulfilled orders after last year’s COVID disruptions though slowing global growth is darkening the outlook. Outbound shipments last month from the world’s second largest…

Read More

Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market

By Michael Erman NEW YORK (Reuters) – The enormous demand for weight-loss treatments like Novo Nordisk’s Wegovy could support as many as 10 competing products with annual sales reaching up to $100 billion within a decade, mostly in the United States, industry executives and analysts said. More than half a dozen companies, from Pfizer Inc…

Read More

Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach

By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) -An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease….

Read More